Clinical Trials · NCT02077946
A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,059
- Start date
- Feb 2014
- Locations
- 1 site, Sweden
- Primary endpoint
- Percent (%) of patients achieving at least 1 %-point HbA1c (glycosylated haemoglobin) reduction